SVB Securities Maintains a Hold Rating on Pfizer (PFE)
In a report released today, David Risinger from SVB Securities
maintained a Hold rating on Pfizer (PFE – Research Report), with a
price target of $53.00. The company's shares closed last Thursday
at $50.72. According to TipRanks.com, Risinger is a 3-star analyst
with an average return of 4.5% and a 68.4% success rate. Risinger
covers the Healthcare sector, focusing on stocks such as Vertex
Pharmaceuticals, Prometheus Biosciences, and Horizon Therapeutics.
Pfizer has an analyst consensus of Moderate Buy, with a price
target consensus of $56.67, representing an 11.5% upside. In a
report issued on July 15, Berenberg Bank also maintained a Hold
rating on the stock with a $50.
から 9 2022 まで 10 2022
から 10 2021 まで 10 2022